Adding senior banker with two decades of
Wall Street experience underscores the ability of healthcare
franchise to attract top talent
Jackson extends the group's coverage to
pharma services and supply chain
NEW
YORK, Oct. 4, 2023 /PRNewswire/ -- Oppenheimer
& Co. Inc. (Oppenheimer) — a leading investment bank, wealth
manager, and a subsidiary of Oppenheimer Holdings (NYSE: OPY) —
announced today that it has expanded its Healthcare Investment
Banking Group with the addition of senior banker Matt Jackson. He will be based in the firm's
Miami offices and report to
Marc Cabrera, Co-Head of Healthcare
Investment Banking.
In his role, Jackson will serve as a Managing Director and be
responsible for expanding the firm's sector coverage to pharma
services and supply chain. He brings over 20 years of Wall Street
experience to the Healthcare Investment Banking Group.
"Oppenheimer has always had strong health services and
biotech/pharma franchises, and Matt's addition to the team only
makes them stronger," Cabrera said. "Matt's coverage of pharma
services and supply chain is the perfect bridge between our two
power alleys. Given the significant amount of private equity and
strategic M&A activity across Matt's sector, we're excited to
have him expand our presence in this important vertical."
Most recently, Jackson was a Partner at MTS Health Partners, a
boutique M&A advisory firm focused exclusively on the
healthcare sector. Prior to 2019, he spent the majority of his
healthcare services investment banking career at Deutsche Bank and
Evercore. During his time on Wall Street, he also spent five years
in healthcare equity research at Bank of America.
"I am extremely excited to join Oppenheimer's healthcare
services team in their Miami
office and the broader U.S. healthcare advisory coverage effort. I
look forward to helping the team expand our sector focus areas
across additional services verticals and bringing complementary
corporate and sponsor relationships to the firm," Jackson said.
Oppenheimer's Healthcare Group now stands at nine senior
bankers, all of whom have extensive transaction experience and are
dedicated to providing world class advice and financing solutions
across the life sciences, health services, health tech and med tech
sectors.
Oppenheimer & Co. Inc.
Oppenheimer & Co. Inc.
(Oppenheimer), a principal subsidiary of Oppenheimer Holdings Inc.
(OPY on the New York Stock Exchange), and its affiliates provide a
full range of wealth management, securities brokerage and
investment banking services to high net-worth individuals,
families, corporate executives, local governments, businesses and
institutions.
Media Contact:
Joseph Kuo / Michael Dugan
Haven Tower Group LLC
424 317 4851 or 424 317 4852
jkuo@haventower.com or mdugan@haventower.com
View original
content:https://www.prnewswire.com/news-releases/oppenheimer-expands-healthcare-investment-banking-team-with-addition-of-matt-jackson-301942691.html
SOURCE Oppenheimer & Co. Inc.